TEMECULA, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- FFF Enterprises Inc., recognized as the nation's most trusted specialty drug distributor and diversified healthcare company, has partnered with the industry’s top pharmaceutical manufacturers to carry Moderna and Novavax COVID-19 vaccines, ABRYSVO™ and AREXVY RSV vaccines, as well as RSV monoclonal antibody, Beyfortus™ — these products, along with our comprehensive portfolio of influenza vaccines, give healthcare providers the arsenal they need to combat the fast approaching 2023-2024 viral respiratory season.
“FFF has been a leader in influenza vaccine distribution, so adding a variety of COVID-19 vaccines and RSV products to our portfolio feels instinctive to continue protecting patients and healthcare providers against viral spread, especially as we continue to hear about emerging COVID-19 variants, and we enter respiratory disease season,” said Patrick M. Schmidt, chief executive officer of FFF Enterprises. “We continue to stay true to our mission of Helping Healthcare Care®, which not only includes a commitment to keeping patients safe, but also ensuring medical staff feel protected and equipped.”
To learn more about FFF Enterprises’ expanding vaccine portfolio, or if you are a medical professional wishing to place an order, visit MyFluVaccine.com.
About Moderna® COVID-19 Vaccines (mRNA)
For more information—including prescribing information—about Moderna COVID-19 Vaccines, please click here. For updated FDA information regarding COVID-19 vaccines, please click here.
About Novavax COVID-19 Vaccine (Adjuvanted/Protein Subunit)
For more information—including prescribing information—about the Novavax COVID-19 Vaccine, please click here. For updated FDA information regarding COVID-19 vaccines, please click here.
About RSV Products
For more information—including prescribing information—about ABRYSVO™, AREXVY, and Beyfortus™, please click here.
About Quadrivalent Influenza Products
For more information—including prescribing information—about Afluria®, Fluad®, FLUARIX®, Flublok®, Flucelvax®, FLULAVAL®, FluMist®, Fluzone®, and Fluzone® High-Dose please click here.
About FFF Enterprises Inc.
Founded in 1988, FFF Enterprises Inc. is a privately held, multibillion-dollar specialty pharmaceutical distributor and diversified healthcare company. FFF Enterprises is the parent company to leading specialty pharmacy Nufactor, Inc., as well as InCircle, LLC and RightNow Inventory™. Our partners include global pharmaceutical and biologics manufacturers, prestigious healthcare systems, large and independent retail pharmacies, and leading alternate care sites. Our nationwide commerce is supported by a network of distribution and infusion pharmacy locations utilizing world-class technology and cybersecurity solutions. Please visit FFF Enterprises' news site, as well as LinkedIn, Twitter, Facebook, Instagram, and YouTube for more information about the company.
Attachment
Michelle Valenzuela FFF Enterprises.com (951) 296-2528 ext 1410 mvalenzuela@fffenterprises.com
